Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial body mass index and hoping to better identify people who need treatment for ...
Treatment of isoniazid- and rifampin-susceptible TB in adults: A 4-month regimen of isoniazid, rifapentine, moxifloxacin, and ...
At federal health agencies, veterans hospitals, and local and state health departments, compliance took a variety of forms. At the Centers for Disease Control and Prevention, employees hurried to ...
The interim leader of the National Institutes of Health gave some clarification tied to Trump administrations restrictions on ...
Kennedy’s potential ascent as HHS secretary brings promise for backers of alternative-health approaches, while skeptics say ...
New recommendations on how to define obesity would reduce the emphasis on body mass index and also take into account health problems from extra weight and other measurements ...
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
The American Heart Association has issued the 2025 update to its annual heart disease and stroke statistics report, detailing ...
Heart disease is once again the leading cause of death in the U.S., according to a new statistical report from the American ...
according to the latest data from the Centers for Disease Control and Prevention (CDC). Current data from the CDC’s NoroSTAT monitoring system show 495 reported outbreaks during the period from ...